Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.580
+0.040 (7.39%)
Nov 21, 2024, 4:00 PM EST - Market closed

MTNB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
347108218272369
Upgrade
Market Cap Growth
-37.13%-56.68%-50.35%-19.56%-26.50%452.45%
Upgrade
Enterprise Value
-53280169217345
Upgrade
Last Close Price
0.5810.8125.0050.5068.00113.50
Upgrade
PS Ratio
-42.8634.016618.481714.824113.26
Upgrade
PB Ratio
0.192.442.964.164.2611.18
Upgrade
P/TBV Ratio
1.232.623.074.274.6313.32
Upgrade
EV/Sales Ratio
-29.6224.975133.741367.863842.74
Upgrade
Debt / Equity Ratio
0.190.180.110.090.060.13
Upgrade
Asset Turnover
-0.030.060.000.000.00
Upgrade
Quick Ratio
5.085.256.7111.4116.458.97
Upgrade
Current Ratio
5.535.938.0611.7317.259.66
Upgrade
Return on Equity (ROE)
-108.57%-82.11%-47.11%-40.07%-46.39%-70.63%
Upgrade
Return on Assets (ROA)
-54.63%-42.49%-28.96%-23.37%-27.21%-39.30%
Upgrade
Return on Capital (ROIC)
-60.19%-46.74%-31.38%-24.80%-28.88%-43.95%
Upgrade
Earnings Yield
-726.44%-48.84%-19.36%-10.66%-8.27%-4.70%
Upgrade
FCF Yield
-582.82%-32.99%-18.49%-7.09%-6.40%-3.92%
Upgrade
Buyback Yield / Dilution
-7.93%-0.21%-3.16%-6.75%-35.61%-48.00%
Upgrade
Total Shareholder Return
-7.93%-0.21%-3.16%-6.75%-35.61%-48.00%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.